The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients.
Ozan Cem GulerB EngelsC OnalH EveraertR Van den BeginT GevaertM de RidderPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2017)
By providing optimal LC, low toxicity and a promising PFS in CS patients, the current retrospective study illustrated that 68Ga PSMA PET-CT-guided RT may be an attractive treatment strategy in patients with oligometastatic prostate cancer. Validation by randomized trials is eagerly awaited.
Keyphrases
- pet ct
- positron emission tomography
- prostate cancer
- radical prostatectomy
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- computed tomography
- prognostic factors
- radiation therapy
- peritoneal dialysis
- pet imaging
- squamous cell carcinoma
- simultaneous determination
- radiation induced
- high resolution